IL133038A0 - Novel diagnosis and treatment for atherosclerosis - Google Patents

Novel diagnosis and treatment for atherosclerosis

Info

Publication number
IL133038A0
IL133038A0 IL13303899A IL13303899A IL133038A0 IL 133038 A0 IL133038 A0 IL 133038A0 IL 13303899 A IL13303899 A IL 13303899A IL 13303899 A IL13303899 A IL 13303899A IL 133038 A0 IL133038 A0 IL 133038A0
Authority
IL
Israel
Prior art keywords
atherosclerosis
treatment
novel diagnosis
diagnosis
novel
Prior art date
Application number
IL13303899A
Original Assignee
Savyon Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Savyon Diagnostics Ltd filed Critical Savyon Diagnostics Ltd
Priority to IL13303899A priority Critical patent/IL133038A0/en
Priority to AU14106/01A priority patent/AU1410601A/en
Priority to PCT/IL2000/000764 priority patent/WO2001036976A2/en
Publication of IL133038A0 publication Critical patent/IL133038A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56933Mycoplasma
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
IL13303899A 1999-11-18 1999-11-18 Novel diagnosis and treatment for atherosclerosis IL133038A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL13303899A IL133038A0 (en) 1999-11-18 1999-11-18 Novel diagnosis and treatment for atherosclerosis
AU14106/01A AU1410601A (en) 1999-11-18 2000-11-16 Novel diagnosis and treatment for atherosclerosis
PCT/IL2000/000764 WO2001036976A2 (en) 1999-11-18 2000-11-16 Novel diagnosis and treatment for atherosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13303899A IL133038A0 (en) 1999-11-18 1999-11-18 Novel diagnosis and treatment for atherosclerosis

Publications (1)

Publication Number Publication Date
IL133038A0 true IL133038A0 (en) 2001-03-19

Family

ID=11073507

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13303899A IL133038A0 (en) 1999-11-18 1999-11-18 Novel diagnosis and treatment for atherosclerosis

Country Status (3)

Country Link
AU (1) AU1410601A (en)
IL (1) IL133038A0 (en)
WO (1) WO2001036976A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7191748B2 (en) 2003-02-13 2007-03-20 Siemens Canada Limited Integrated air and fuel carrier module

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69026496D1 (en) * 1989-10-13 1996-05-15 Neurofit ANALOGS OF VITAMIN A AND THEIR USE, IN PARTICULAR AS CYTOTROPHIC AND CYTOPROTECTIVE SUBSTANCES AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease

Also Published As

Publication number Publication date
WO2001036976A3 (en) 2001-11-01
WO2001036976A2 (en) 2001-05-25
AU1410601A (en) 2001-05-30

Similar Documents

Publication Publication Date Title
GB0013515D0 (en) Endoscope
GB9910938D0 (en) Diagnostic apparatus
EP1223932A4 (en) Compounds and methods
EP1146790A4 (en) Compounds and methods
GB9925136D0 (en) Novel treatment
IL144186A0 (en) Novel treatment
GB9911772D0 (en) Diagnosis and treatment of atherosclerosis
GB2339576B (en) Biomass treatment
GB9926805D0 (en) Diagnostic methods
EP1194439A4 (en) Human eag2
GB9929720D0 (en) Diagnostic method
IL133038A0 (en) Novel diagnosis and treatment for atherosclerosis
GB2351297B (en) Metallurgical treatment apparatus
GB9920336D0 (en) Retinoscope
GB9922482D0 (en) Method of diagnosis
GB9815497D0 (en) Treatment
GB9818524D0 (en) Inorgasmia treatment
GB9919721D0 (en) Medical apparatus
GB9828550D0 (en) Treatment
TW387258U (en) Medical air-sucker
GB9908993D0 (en) Treatment
HU9904416D0 (en) Blood-pressure apparatus
AU141196S (en) Tissue
GB9920787D0 (en) Novel treatment
GB9920788D0 (en) Novel treatment